Sword Health stock $50.17 USD

Private-market facts for current and former Sword Health employees researching their stock.

Latest Round
Series D
Valuation
$4B
Founded
2015
Headquarters
Draper, UT
Founders
Virgilio Bento
Status
private

Price per share sourced from public secondary-market data. Updated April 2026. Indicative only — not a live quote.

Talk to a Sword Health stock specialist

Get personalized guidance on your Sword Health shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Digital musculoskeletal care platform that uses AI and motion-tracking wearable sensors to deliver physical therapy programs remotely through employer health plans.

Sword Health outlook

Equity outlook100% data confidence
1x
Base scenario
1x
Upside scenario

For employees evaluating Sword Health equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices.

These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.

Illustrative model · v1.0.0 · Not investment advice

Selling Sword Health shares

Why shareholders consider selling

Shareholders in Sword Health may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Sword Health does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Sword Health stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Sword Health shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Sword Health shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series D round, its reported $4B valuation and recent secondary-market pricing can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

  • The type of security held (common shares, preferred, options, RSUs)
  • Whether the equity is fully vested and, for options, whether it has been exercised
  • Any transfer restrictions, lock-up provisions, or company approval requirements
  • Estimated net proceeds after applicable taxes and transaction fees
  • Whether partial liquidity — selling a portion rather than the full position — may be a better fit

Tools for Sword Health shareholders

Exploring equity in Sword Health often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Sword Health most recently raised a Series D round in June 2024. The company was valued at $4B. Total funding raised to date is approximately $340M.

Lead investors in this round include General Atlantic and Sapphire Ventures.

Founders & company background

Sword Health was founded in 2015 by Virgilio Bento and is headquartered in Draper, UT.

Investors

Industry

Similar private companies

Latest Sword Health news

Talk to a Sword Health stock specialist

Get personalized guidance on your Sword Health shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Sword Health still a private company?
Yes, Sword Health is currently a private company.
What is Sword Health's latest funding round?
Sword Health's most recent known round is Series D, raised in June 2024.
What is Sword Health's valuation?
Sword Health's latest reported valuation is $4B.
Who are the investors in Sword Health?
Notable investors include General Atlantic, Sapphire Ventures, Khosla Ventures, BOND.
Can I sell my Sword Health stock?
Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Sword Health stock can help you evaluate your options.

Related pages

Last verified: 2026-04-13 · Sword Health data compiled from funding disclosures, investor announcements, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.